News
Blood group O linked to decreased risk of SARS-CoV-2 infection
- Author:
- Mark S. Lesney, PhD
Publish date: October 15, 2020
News
Study: Complications from childhood ALL and its treatment are common, but can be managed
- Author:
- Mark S. Lesney, PhD
Publish date: October 15, 2020
News
Older adults with multiple myeloma face heavy burden of care
- Author:
- Mark S. Lesney, PhD
Publish date: October 8, 2020
Article
Meta-analysis: Acalabrutinib showed better PFS and OS than other frontline CLL therapies
- Author:
- Mark S. Lesney, PhD
Publish date: October 7, 2020
News
Orthopedic problems in children can be the first indication of acute lymphoblastic leukemia
- Author:
- Mark S. Lesney, PhD
Publish date: September 30, 2020
News
Initial response to novel agents preps MM patients for favorable transplant outcomes
- Author:
- Mark S. Lesney, PhD
Publish date: September 24, 2020
News
Two new protein biomarkers may serve as prognostic indicators for outcomes in CLL
- Author:
- Mark S. Lesney, PhD
Publish date: September 23, 2020
News
Low VWF levels or blood group O not linked to intracerebral hemorrhage risk
- Author:
- Mark S. Lesney, PhD
Publish date: September 10, 2020
News
Statins linked to improved survival in multiple myeloma
- Author:
- Mark S. Lesney, PhD
Publish date: September 10, 2020
News
Oxidative stress linked to cytogenetic abnormalities in CLL
- Author:
- Mark S. Lesney, PhD
Publish date: September 9, 2020
News
CSF metabolomic profile linked to cancer-related fatigue in children with ALL
- Author:
- Mark S. Lesney, PhD
Publish date: September 8, 2020
Opinion

Chronicles of Cancer: A history of mammography, part 2
- Author:
- Mark S. Lesney, PhD
Publish date: September 4, 2020
News
Napabucasin suppressed tumor growth in DLBCL cell lines
- Author:
- Mark S. Lesney, PhD
Publish date: September 2, 2020
News
Age, other risk factors predict length of MM survival
- Author:
- Mark S. Lesney, PhD
Publish date: August 27, 2020
News
Antihistamines synergistically induce CLL cell death with TK inhibitors
- Author:
- Mark S. Lesney, PhD
Publish date: August 26, 2020